Clinical Trial Update: Immune Reconstitution in HIV Disease (IREHIV) [Phase 2]

View source ↗

Summary

Phase 2 trial update on immune reconstitution in HIV disease (IREHIV) sponsored by Karolinska Institutet. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Karolinska Institutet | Conditions: HIV Infection | Phase 2 | Status: COMPLETED